BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22635234)

  • 21. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
    Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
    Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
    Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
    Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies.
    Amengual O; Horita T; Binder W; Norman GL; Shums Z; Kato M; Otomo K; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Atsumi T
    Rheumatol Int; 2014 Sep; 34(9):1225-30. PubMed ID: 24497039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
    Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a commercially available kit to detect anti-phosphatidylserine/prothrombin antibodies in a cohort of systemic lupus erythematosus patients.
    Sciascia S; Sanna G; Murru V; Khamashta MA; Bertolaccini ML
    Thromb Res; 2014 Mar; 133(3):451-4. PubMed ID: 24342537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome].
    Kaburaki J; Kuwana M; Ikeda Y
    Rinsho Ketsueki; 2003 Jan; 44(1):28-30. PubMed ID: 12649835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiprothrombin antibodies--are they worth assaying?
    Atsumi T; Amengual O; Yasuda S; Koike T
    Thromb Res; 2004; 114(5-6):533-8. PubMed ID: 15507288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome.
    Sciascia S; Bertolaccini ML
    Lupus; 2014 Oct; 23(12):1309-12. PubMed ID: 25228735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
    Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
    Front Immunol; 2021; 12():754469. PubMed ID: 34790198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microangiopathic antiphospholipid antibody syndrome due to anti-phosphatidylserine/prothrombin complex IgM antibody.
    Senda Y; Ohta K; Yokoyama T; Shimizu M; Furuichi K; Wada T; Yachie A
    Pediatr Int; 2017 Mar; 59(3):378-380. PubMed ID: 28317300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.
    Žigon P; Čučnik S; Ambrožič A; Kveder T; Šemrl SS; Rozman B; Božič B
    Clin Dev Immunol; 2013; 2013():724592. PubMed ID: 24187565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies.
    Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S
    Immunol Res; 2021 Aug; 69(4):372-377. PubMed ID: 34245429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
    de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
    Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome.
    de Laat B; Derksen RH; Mackie IJ; Roest M; Schoormans S; Woodhams BJ; de Groot PG; van Heerde WL
    Ann Rheum Dis; 2006 Nov; 65(11):1468-72. PubMed ID: 16449315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity.
    Yang YH; Chang CJ; Chuang YH; Hsu HY; Chen PP; Chiang BL
    Rheumatology (Oxford); 2010 Jan; 49(1):34-42. PubMed ID: 19920091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    Canti V; Del Rosso S; Tonello M; Lucianò R; Hoxha A; Coletto LA; Vaglio Tessitore I; Rosa S; Manfredi AA; Castiglioni MT; Ruffatti A; Rovere-Querini P
    J Rheumatol; 2018 Aug; 45(9):1263-1272. PubMed ID: 30008452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.